1.
Jpn J Antibiot
; 37(12): 2506-18, 1984 Dec.
Artigo
em Japonês
| MEDLINE
| ID: mdl-6098743
RESUMO
Clinical evaluation of cefmenoxime (CMX, Bestcall) was examined in the infection associated with hematological disorders, respiratory tract and other disorders. Clinical effectiveness for severe infection of hematological disorders was 47.4% in good and 84.2% in fair response, however, in the respiratory tract infections, 89.7% in good response was obtained. Opportunistic infection due to Gram-negative bacilli are often experienced in patients with hematological disorders. It was discussed that CMX would be a good therapeutic agent against infectious diseases associated with hematological disorders because it's antibacterial spectrum would be parallel to pathogens of such disorders.
Assuntos
Infecções Bacterianas/tratamento farmacológico , Cefotaxima/análogos & derivados , Doenças Hematológicas/complicações , Adolescente , Adulto , Idoso , Cefmenoxima , Cefotaxima/administração & dosagem , Cefotaxima/uso terapêutico , Feminino , Humanos , Infusões Parenterais , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Infecções Respiratórias/tratamento farmacológico , Infecções Urinárias/tratamento farmacológico
2.
Nihon Rinsho
; 49(8): 1927-39, 1991 Aug.
Artigo
em Japonês
| MEDLINE
| ID: mdl-1787601
3.
Josanpu Zasshi
; 33(8): 567, 1979 Aug.
Artigo
em Japonês
| MEDLINE
| ID: mdl-259704